Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Curran

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|April 3, 2013
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of EomesoderminMichael A Curran, Theresa L Geiger, Welby Montalvo, et al.
Cell Transplantation|December 3, 2008
Protection of human pancreatic islets using a lentiviral vector expressing two genes: cFLIP and GFPElizabeth S Fenjves, M Sofia Ochoa, Sirlene Cechin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine GlioblastomaC Elizabeth Boudreau, Hinda Najem, Martina Ott, et al.
Journal for Immunotherapy of Cancer|October 30, 2024
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinomaRicardo DeAzevedo, Madeline Steiner, Broderick X Turner, et al.
Oncoimmunology|December 21, 2020
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanomaRicardo A de Azevedo, Einav Shoshan, Shanzhi Whang, et al.
Transplantation|August 15, 2002
Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors1Michael A Curran, M Sofia Ochoa, R Damaris Molano, et al.
Neuro-Oncology|November 4, 2019
Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implicationsJun Wei, Peiwen Chen, Pravesh Gupta, et al.
ACS Chemical Biology|May 1, 2020
mRNA Display Discovery of a Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)Golnaz Kamalinia, Brian J Engel, Anupallavi Srinivasamani, et al.
Frontiers in Immunology|November 28, 2022
Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical dataJi Son, Rodney Cheng-En Hsieh, Heather Y Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2026
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibodyAhmad Salameh, Elisabetta Bolli, Manuela Iezzi, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|April 3, 2013
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of EomesoderminMichael A Curran, Theresa L Geiger, Welby Montalvo, et al.
Cell Transplantation|December 3, 2008
Protection of human pancreatic islets using a lentiviral vector expressing two genes: cFLIP and GFPElizabeth S Fenjves, M Sofia Ochoa, Sirlene Cechin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine GlioblastomaC Elizabeth Boudreau, Hinda Najem, Martina Ott, et al.
Journal for Immunotherapy of Cancer|October 30, 2024
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinomaRicardo DeAzevedo, Madeline Steiner, Broderick X Turner, et al.
Oncoimmunology|December 21, 2020
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanomaRicardo A de Azevedo, Einav Shoshan, Shanzhi Whang, et al.
Transplantation|August 15, 2002
Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors1Michael A Curran, M Sofia Ochoa, R Damaris Molano, et al.
Neuro-Oncology|November 4, 2019
Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implicationsJun Wei, Peiwen Chen, Pravesh Gupta, et al.
ACS Chemical Biology|May 1, 2020
mRNA Display Discovery of a Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)Golnaz Kamalinia, Brian J Engel, Anupallavi Srinivasamani, et al.
Frontiers in Immunology|November 28, 2022
Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical dataJi Son, Rodney Cheng-En Hsieh, Heather Y Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2026
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibodyAhmad Salameh, Elisabetta Bolli, Manuela Iezzi, et al.
Pageof 9